Works by Venkatakrishnan, Karthik

Results: 136
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper.

    Published in:
    Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 531, doi. 10.1002/cpt.3298
    By:
    • Samineni, Divya;
    • Venkatakrishnan, Karthik;
    • Othman, Ahmed A.;
    • Pithavala, Yazdi K.;
    • Poondru, Srinivasu;
    • Patel, Chirag;
    • Vaddady, Pavan;
    • Ankrom, Wendy;
    • Ramanujan, Saroja;
    • Budha, Nageshwar;
    • Wu, Michael;
    • Haddish‐Berhane, Nahor;
    • Fritsch, Holger;
    • Hussain, Azher;
    • Kanodia, Jitendra;
    • Li, Meng;
    • Li, Mengyao;
    • Melhem, Murad;
    • Parikh, Apurvasena;
    • Upreti, Vijay V.
    Publication type:
    Article
    14
    15

    Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial.

    Published in:
    Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 6, p. 1346, doi. 10.1002/cpt.3216
    By:
    • Klopp‐Schulze, Lena;
    • Gopalakrishnan, Sathej;
    • Yalkinoglu, Özkan;
    • Kuroki, Yoshihiro;
    • Lu, Hong;
    • Goteti, Kosalaram;
    • Krebs‐Brown, Axel;
    • Nogueira Filho, Marco;
    • Gradhand, Ulrike;
    • Fluck, Markus;
    • Shaw, Jamie;
    • Dong, Jennifer;
    • Venkatakrishnan, Karthik
    Publication type:
    Article
    16
    17

    Model‐Informed Selection of the Recommended Phase III Dose of the Inhibitor of Apoptosis Protein Inhibitor, Xevinapant, in Combination with Cisplatin and Concurrent Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

    Published in:
    Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 1, p. 52, doi. 10.1002/cpt.3065
    By:
    • Vugmeyster, Yulia;
    • Ravula, Abhigyan;
    • Rouits, Elisabeth;
    • Diderichsen, Paul Matthias;
    • Kleijn, Huub Jan;
    • Koenig, Andre;
    • Wang, XiaoZhe;
    • Schroeder, Andreas;
    • Goteti, Kosalaram;
    • Venkatakrishnan, Karthik
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective.

    Published in:
    Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 4, p. 770, doi. 10.1002/cpt.2503
    By:
    • Hariparsad, Niresh;
    • Ramsden, Diane;
    • Taskar, Kunal;
    • Badée, Justine;
    • Venkatakrishnan, Karthik;
    • Reddy, Micaela B.;
    • Cabalu, Tamara;
    • Mukherjee, Dwaipayan;
    • Rehmel, Jessica;
    • Bolleddula, Jayaprakasam;
    • Emami Riedmaier, Arian;
    • Prakash, Chandra;
    • Chanteux, Hugues;
    • Mao, Jialin;
    • Umehara, Kenichi;
    • Shah, Kushal;
    • De Zwart, Loeckie;
    • Dowty, Martin;
    • Kotsuma, Masakatsu;
    • Li, Mengyao
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1439, doi. 10.1007/s00280-011-1637-5
    By:
    • Leal, Ticiana;
    • Remick, Scot;
    • Takimoto, Chris;
    • Ramanathan, Ramesh;
    • Davies, Angela;
    • Egorin, Merrill;
    • Hamilton, Anne;
    • LoRusso, Patricia;
    • Shibata, Stephen;
    • Lenz, Heinz-Josef;
    • Mier, James;
    • Sarantopoulos, John;
    • Mani, Sridhar;
    • Wright, John;
    • Ivy, S.;
    • Neuwirth, Rachel;
    • Moltke, Lisa;
    • Venkatakrishnan, Karthik;
    • Mulkerin, Daniel
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50